HIGHLIGHTS Coronavirus Disease 2019 (COVID-19) Situation Report 77
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Coronavirus Disease 2019 (COVID-19) World Health
Organization
Situation Report
n - 77
Indonesia
19 October 2021
HIGHLIGHTS
• As of 19 October, the Government of Indonesia reported
4 236 287 (903 new) confirmed cases of COVID-19,
143 049 (50 new) deaths and 4 076 541 recovered cases
from 510 districts across 34 provinces.1 As of the same
date, the number of people fully vaccinated per 100 total
population was 23.6 nationwide; DKI Jakarta reported the
highest number among all provinces (78.7). The weekly
number of COVID-19 vaccine doses administered from
11 to 17 October was 11 372 005 doses.2
• As of 17 October, the weekly incidence per 100 000
population nationwide, in Java-Bali and non-Java-Bali
regions was 3.2, 2.8 and 3.7, respectively. The weekly
incidence remained at a low level of community
transmission (CT1).
Fig. 1. Geographic distribution of confirmed COVID-19 cases reported in the last seven days per 100 000
population in Indonesia across provinces, from 13 to 19 October 2021. Source of data
Disclaimer: The number of cases reported daily is not equivalent to the number of persons who
contracted COVID-19 on that day; reporting of laboratory-confirmed results may take up to one week
from the time of testing.
1
https://covid19.go.id/peta-sebaran-covid19
2
https://vaksin.kemkes.go.id/#/vaccines
1
WHO Indonesia Situation Report - 77
who.int/indonesia
GENERAL UPDATES
• On 15 October, the Ministry of Health (MoH) spokesperson for COVID-19
vaccination reported that more than 50% of the target population in Indonesia have
been vaccinated with at least one dose of the vaccine. She appreciated the active
participation from the public and continuous support from various stakeholders,
including from the private sector. The MoH spokesperson highlighted that the
government will continue to implement strategies to accelerate vaccination in the
country to reach the remaining target population, in collaboration with relevant
partners and stakeholders. She reiterated the importance of continuous
improvement of vaccination coverage as one of the efforts to curb COVID-19
transmission and provide protection to the community. 3
• The Government of Indonesia reopened Bali for international tourists on 14
October. The decision was implemented as one of the strategies to support the
acceleration of national economic recovery. The Deputy Governor of Bali said that
strategies have been developed and preparations have been made to anticipate
the incoming tourists and to control COVID-19 transmission in the province. As of
14 October, no international arrivals via the I Gusti Ngurah Rai International Airport
were recorded. The Deputy Governor expected that more international tourists will
come to Bali by the end of October 2021 or early next year.4
• On 13 October, the National COVID-19 Task Force (Satuan Tugas (Satgas))
issued a new Circular No. 14 of 2021 on ‘Entry Point, Quarantine Place, and
Mandatory Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Test for
Indonesian Citizens from Abroad’. According to the circular, seven points of entry
(PoEs) have been designated for Indonesian citizens coming from abroad to enter
the country: the Soekarno-Hatta International Airport in Banten, Sam Ratulangi
International Airport in North Sulawesi, Batam Central Harbour and Tanjung
Pinang Harbour in Riau Islands, Nunukan Harbour in North Kalimantan, and the
Aruk and Entikong Cross-Border Posts in West Kalimantan. Upon arrival,
Indonesian citizens coming from countries with low COVID-19 transmission are
required to undergo a mandatory quarantine for five days; those coming from
countries with high COVID-19 transmission are required to undergo mandatory
quarantine for 14 days. Centralized quarantine facilities have been prepared by
the government, especially for Indonesian migrant workers, government officials
returning from official travel, and students returning to the country. This circular is
effective until 31 December 2021.5
3
https://www.kemkes.go.id/article/view/21101500002/vaksinasi-covid-19-dosis-pertama-lampaui-50-
persen-sasaran-terima-kasih-masyarakat-indonesia.html
4
https://en.tempo.co/read/1517772/foreign-tourists-likely-to-swarm-bali-in-octobers-end
5
https://www.cnbcindonesia.com/news/20211014085432-4-283785/satgas-covid-tetapkan-7-pintu-
masuk-wni-ke-ri-ini-daftarnya
2
WHO Indonesia Situation Report - 77
who.int/indonesia
SURVEILLANCE
• On 19 October, 903 new and 4 236 287 cumulative cases were reported in
Indonesia. The weekly number of cases from 11 to 17 October was 6826, a
decrease of 21% compared to the previous week. On 19 October, 50 new and
143 049 cumulative COVID-19 deaths were reported nationwide. The weekly
number of new deaths from 11 to 17 October was 301, a decrease of 37%
compared to the previous week (Fig. 2).
400000 14000
350000 12000
300000
10000
250000
8000
Deaths
Cases
200000
6000
150000
4000
100000
50000 2000
0 0
23/03 - 29/03
13/04 - 19/04
25/05 - 31/05
15/06 - 21/06
17/08 - 23/08
07/09 - 13/09
19/10 - 25/10
09/11 - 15/11
11/01 - 17/01
15/03 - 21/03
05/04 - 11/04
07/06 - 13/06
09/08 - 15/08
30/08 - 05/09
02/03 - 08/03
04/05 - 10/05
06/07 - 12/07
27/07 - 02/08
28/09 - 04/10
30/11 - 06/12
21/12 - 27/12
01/02 - 07/02
22/02 - 28/02
26/04 - 02/05
17/05 - 23/05
28/06 - 04/07
19/07 - 25/07
20/09 - 26/09
11/10 - 17/10
Weekly number of confirmed COVID-19 cases Weekly number of confirmed COVID-19 deaths
Fig. 2. Weekly number of confirmed COVID-19 cases and deaths reported in Indonesia, as of 17 October
2021. Source of data
Disclaimer: Prior to 10 February 2021, SARS-CoV-2 diagnosis was conducted using polymerase chain
reaction (PCR). Since this date, confirmed cases include those who tested positive using nucleic acid
amplification test (NAAT) (e.g., PCR) and antigen-detecting rapid diagnostic test (Ag-RDT). The number
of cases reported daily is not equivalent to the number of persons who contracted COVID -19 on that day
and might be influenced by the number of people tested on that day (see Fig. 6); reporting of
laboratory-confirmed results may take up to one week from the time of testing. Therefore, caution must
be taken in interpreting this figure and the epidemiological curve for further analysis, b oth at the national
and subnational level.
3
WHO Indonesia Situation Report - 77
who.int/indonesia
• From 11 to 17 October, the weekly COVID-19 incidence per 100 000 population
nationwide, in Java-Bali region and in provinces outside Java-Bali region
(non-Java-Bali) was 3.2, 2.8 and 3.7, respectively (Fig. 3). The weekly incidence in
Java-Bali region has remained at a low level of community transmission (CT1) for
the past six weeks, while the weekly incidence nationwide and in non-Java-Bali
region has remained at CT1 for the past five weeks. Province and district level
analyses are needed to evaluate these trends and identify new clusters if they arise.
160
CT4 (150+)
140
120
Case incidence
100 CT3 (50 -
• During the week of 11 to 17 October, North Kalimantan was the only province at a
moderate level of community transmission (CT2), with an incidence of 32.4 per
100 000 population (Fig. 4). Based on the WHO interim guidance, this means that
there was a moderate risk of COVID-19 infection for the general population and a
moderate incidence of locally acquired, widely dispersed cases detected in the past
14 days. The remaining 33 provinces were at community transmission level 1 (CT1)
during this reporting period (Fig. 4).
North Kalimantan
Bangka Belitung Islands
East Kalimantan
Bali
DKI Jakarta
DI Yogyakarta
West Papua
Central Sulawesi
North Sulawesi
West Kalimantan
West Sulawesi
East Nusa Tenggara
Papua
Central Kalimantan
Aceh
South Sulawesi
Riau Islands
Riau
South Kalimantan
West Sumatra
North Maluku
North Sumatra
Central Java
East Java
Lampung
Jambi
Banten
West Nusa Tenggara
West Java
Bengkulu
Maluku
South Sumatra
Gorontalo
Southeast Sulawesi
0 5 10 15 20 25 30 35
Weekly case incidence
CT 1 (• Case incidence in all regions continued to decline over the past ten weeks (Fig. 5).
It is critical for each administrative level to closely monitor any possible cluster to
ensure rapid response and containment of an outbreak in time. Exhaustive contact
tracing activities for each identified case are essential to prevent the spread of
infection. Details on incidence in each province are available here.
160
CT4 (150+)
140
120
100 CT3 (50 -• Nationwide test positivity proportion has remained below 2% in the last four weeks.
This proportion can be interpreted reliably only with comprehensive surveillance and
testing rate in the order of one person tested per 1000 population per week. Since
mid-May 2021, the testing rate of > 1 per 1000 population per week has been
maintained; in the last five weeks, the rate has been > 4 per 1000 population per
week. It is critical to ensure the continuation of a rigorous testing strategy to rapidly
identify COVID-19 cases among suspected cases and close contacts. Furthermore,
it is essential to conduct separate analysis of testing rate based on the purpose of
testing (e.g., for suspected cases, close contacts and screening) for planning and
response purposes (Table 2. Weekly Risk Assessment, page 15).
4.5 35.0%
35%
4.0
People tested/1000 population/week
30.0%
30%
3.5 CT 4
25.0%
25%
3.0
Test positivity proportion
20.0%
2.5 20%
2.0 15%
15.0%
CT 3
1.5
10.0%
10%
1.0
5.0%
0.5 5% CT 2
0.0 0.0% CT 1
0%
27/04 - 03/05
18/05 - 24/05
08/06 - 14/06
29/06 - 05/07
20/07 - 26/07
10/08 - 16/08
31/08 - 06/09
21/09 - 27/09
12/10 - 18/10
02/11 - 08/11
23/11 - 29/11
14/12 - 20/12
04/01 - 10/01
25/01 - 31/01
15/02 - 21/02
08/03 - 14/03
29/03 - 04/04
19/04 - 25/04
10/05 - 16/05
31/05 - 06/06
21/06 - 27/06
12/07 - 18/07
02/08 - 08/08
23/08 - 29/08
13/09 - 19/09
04/10 - 10/10
People tested/1000 population Test positivity proportion
Fig. 6. Weekly test positivity proportion and people tested per 1000 population per week at the national
level, as of 17 October 2021, classified by level of community transmission (CT): CT1: low incidence
(< 2%); CT2: moderate incidence (2% - < 5%); CT3: high incidence (5% - < 20%); CT4: very high
incidence (20%+). Source of data
Disclaimer: Caution should be exercised when interpreting this indicator due to limitations listed in the
WHO interim guidance. Other epidemiological indicators also need to be evaluated to determine the level
of community transmission.
Disclaimer: Caution should be exercised when interpreting this indicator due to limitations listed in the
WHO interim guidance. Other epidemiological indicators also need to be evaluated to determine the level
of community transmission.
7
WHO Indonesia Situation Report - 77
who.int/indonesia• During the week of 11 to 17 October, the weekly number of confirmed COVID-19
deaths per 100 000 population in North Kalimantan (1.1) remained at the moderate
level of community transmission (CT2). During the same period, the weekly number
of confirmed COVID-19 deaths in the remaining 33 provinces was < 1 death per
100 000 population, corresponding to a low level of community transmission (CT1)
(Fig. 7).
North Kalimantan
Aceh
Bangka Belitung Islands
Papua
Bali
DI Yogyakarta
East Kalimantan
Central Kalimantan
Central Sulawesi
South Kalimantan
Riau
West Sulawesi
Central Java
Lampung
West Sumatra
Riau Islands
East Nusa Tenggara
North Sulawesi
East Java
DKI Jakarta
South Sulawesi
Bengkulu
North Sumatra
Jambi
West Nusa Tenggara
Gorontalo
South Sumatra
West Kalimantan
West Java
Southeast Sulawesi
Banten
Maluku
North Maluku
West Papua
0.0 0.3 0.6 0.9 1.2
Weekly number of confirmed COVID-19 deaths per 100 000
population
CT 1 (• At the national level, during the week of 11 to 17 October, the number of confirmed
COVID-19 deaths in Indonesia was 0.2 per 100 000 population, compared to 0.3
deaths per 100 000 population in the previous week. Deaths in Java-Bali and
non-Java Bali regions also continued to show a declining trend (Fig. 8).
6
CT4 (5+)
5
Deaths per 100 000 population
4
CT3 (2 -HEALTH OPERATIONS
• On 17 October, the reported number of COVID-19 cases hospitalized in
DKI Jakarta was 348, a decrease from 438 cases one week prior. In the same time
period, the reported number of cases in self-isolation decreased from 1285 to 998
cases (Fig. 9).
120000
110000
100000
90000
Number of active cases
80000
70000
60000
50000
40000
30000
20000
10000
0
1-Sep 1-Oct 1-Nov 1-Dec 1-Jan 1-Feb 1-Mar 1-Apr 1-May 1-Jun 1-Jul 1-Aug 1-Sep 1-Oct
Hospitalized Self-isolation
Fig. 9. Number of COVID-19 cases hospitalized and in self-isolation in DKI Jakarta, from 1 September
2020 to 17 October 2021. Source of data
• The overall bed occupancy rate (BOR) in COVID-19 referral hospitals has
continued to decline. On 16 October, BOR at national level remained at 5%,
compared to the week before on 9 October.6 In the same time period, BOR in
intensive care unit (ICU) wards was 8% compared to 10%, respectively.7
6
https://www.kemkes.go.id/downloads/resources/download/Ketersediaan-Tempat-Tidur-RS-
Covid19/BOR-RS-16-OKTOBER-2021.pdf
7
https://www.kemkes.go.id/downloads/resources/download/Ketersediaan-Tempat-Tidur-RS-
Covid19/BOR-RS-9-OKTOBER-2021.pdf
10
WHO Indonesia Situation Report - 77
who.int/indonesiaRISK AND NEEDS ASSESSMENT, AND PLANNING
• On 15 October, WHO supported MoH to conduct a virtual workshop to review the
COVID-19 operational plans of eight priority districts in Riau Islands, Lampung,
West Java, Central Java, Bali, East Kalimantan and North Sulawesi. More than 60
representatives from MoH and relevant Provincial and District Health Offices
(PHOs and DHOs) attended the workshop. WHO presented the ‘COVID-19
Strategic Preparedness and Response Plan Operational Planning Guideline ’,
which highlighted the ten pillars of the COVID-19 response plan: (1) Coordination,
planning, financing, and monitoring; (2) Risk communication, community
engagement and infodemic management; (3) Surveillance, epidemiological
investigation, contact tracing, and adjustment of public health and social
measures; (4) Points of entry, international travel and transport, and mass
gatherings; (5) Laboratories and diagnostics; (6) Infection prevention and control,
and protection of health workforce; (7) Case management, clinical operations, and
therapeutics; (8) Operational support and logistics, and supply chains; (9)
Strengthening essential health services and systems; and (10) Vaccination. WHO
urged districts and provinces to review their COVID-19 response plans on a regular
basis to monitor indicators and achievements, as well as to identify gaps and
challenges to further improve the response plans.
11
WHO Indonesia Situation Report - 77
who.int/indonesiaVACCINATION
• As of 19 October, 173 949 386 vaccine doses have been administered in the
national COVID-19 vaccination campaign; 45 219 980 people (21.7 % of the target
population) have been partially vaccinated8 and 64 364 703 people (30.9% of the
target population) have been fully vaccinated. The weekly number of COVID-19
vaccine doses administered from 11 to 17 October was 11 372 005 doses, a
13.2% increase compared to 10 046 352 doses in the previous week. As of 19
October, the number of people fully vaccinated per 100 total population was 23.6
nationwide; DKI Jakarta reported the highest number of fully vaccinated per 100
population (78.7), followed by Bali (64.6), Riau Islands (42.9) and DI Yogyakarta
(35.8) (Fig. 10).
100
90
per 100 population
Number of people
80
70
60
50
40
30
20
10
0
Bengkulu
Riau Islands
Gorontalo
Maluku
East Java
DI Yogyakarta
Lampung
Jambi
Banten
Central Java
Bali
Riau
Bangka Belitung Islands
DKI Jakarta
West Java
North Sumatra
Southeast Sulawesi
Central Kalimantan
West Nusa Tenggara
Central Sulawesi
Aceh
Papua
North Maluku
South Kalimantan
East Nusa Tenggara
West Papua
West Kalimantan
North Kalimantan
South Sulawesi
West Sulawesi
North Sulawesi
South Sumatra
West Sumatra
East Kalimantan
Fully vaccinated per 100 population Partially vaccinated per 100 population Unvaccinated per 100 population
Fig. 10. Number of people fully vaccinated, partially vaccinated and unvaccinated (zero dose) for
COVID-19 per 100 total population by province in Indonesia, as of 19 October 2021. Source of data
Note: Source of population data: Target population for health programme 2021, Center of Data and
Information, Ministry of Health, unpublished data.
Disclaimer: Data are recorded based on the location of the vaccination site. Total population is
calculated based on provincial data (national identif ication number (Nomor Induk Kependudukan
(NIK)).
8
Partially vaccinated: number of people who have received only the first dose of a two -dose vaccine
regimen (calculated as the number of people who have received the first dose subtracted by the number
of people who have received the second dose).
12
WHO Indonesia Situation Report - 77
who.int/indonesiaTable 1. COVID-19 vaccination by each target population in Indonesia, as of 19 October
2021. Source of data
Number of Number of
Target Total target Number of
partially % fully % %
population population unvaccinated
vaccinated vaccinated
Health workers 1 468 764 125 531 8.5 1 876 805 127.8 0 0
Older people 21 553 118 2 869 556 13.3 4 858 702 22.5 13 824 860 64.1
Essential public 17 327 167 5 749 629 33.2 22 198 350 128.1 0 0
service workers
General
141 211 181 35 397 901 25.1 31 528 227 22.3 74 285 053 52.6
population
Children aged 2 929 067
26 705 490 911 733 3.4 11.0 22 864 690 85.6
12-17
Gotong Royong
164 943 971 955
scheme*
Note: General population includes vulnerable groups (e.g., persons with disabilities, marginalized
groups, etc.); total number vaccinated includes eligible target population with Gotong Royong scheme.
*The Gotong Royong scheme does not have a separate total target population from the government
vaccination programme.
Disclaimer: Vaccination coverage greater than 100% is due to differences in actual versus estimated
target population. Due to the ongoing data cleaning process, vaccination coverage may be temporarily
affected.
• As of 19 October, more than 60% of the older population remains unvaccinated in
28 out of 34 provinces. Two provinces reported a proportion of unvaccinated older
populations greater than 90%: West Sumatra and Papua. From 11 to 17 October,
among the older population, a declining trend in the number of vaccine doses
administered was observed in 15 provinces (DI Yogyakarta, Maluku, West Nusa
Tenggara, Central Java, Riau, Riau Islands, North Sulawesi, North Sumatra, West
Kalimantan, Gorontalo, Central Sulawesi, Jambi, West Papua, Bali and South
Sulawesi). The provinces which showed an increase of > 25% of doses
administered among the older population compared to the previous week were:
Lampung (274.4%), West Sumatra (96.6%), North Kalimantan (71.8%), Central
Kalimantan (46.7%), West Sulawesi (45.1%), West Java (37.1%), East Kalimantan
(30.8%) and Aceh (26.1%).
• An overall decrease in the weekly trend of vaccine doses administered was
observed in 18 out of 34 provinces compared to the previous week. Details of
vaccination by province and target populations are available here.
13
WHO Indonesia Situation Report - 77
who.int/indonesiaPARTNER COORDINATION
• The overall funding request for WHO operations and technical assistance is
US$ 46 million (US$ 27 million for response and US$ 19 million for recovery
phase), based on estimated needs as of October 2021 (Fig. 11).
Fig. 11. WHO funding situation for COVID-19 response, October 2021.
Data presented in this situation report have been taken from publicly available data from the MoH
(https://infeksiemerging.kemkes.go.id; https://vaksin.kemkes.go.id), COVID-19 Mitigation and National
Economic Recovery Team (KPCPEN) (http://covid19.go.id) and provincial websites. There may be
differences in national and provincial data depending on the source used. All data are provisional and
subject to change.
14
WHO Indonesia Situation Report - 77
who.int/indonesiaWEEKLY RISK ASSESSMENT
Table 2. Weekly risk assessment by province in Indonesia, 11 to 17 October 2021.
Source of data: Cases, deaths and testing; vaccination
Note: Case incidence trend considers the trend of cases over the last three weeks. Incidence per 100 000
population is marked as light red if > 150 and orange if between 50 to 150. Death per 100 000 population
is marked as light red if > 5 and orange if between 2 and 5. The testing rate is marked as yellow if it is less
than 1/1000 population. Test positivity proportion is marked as light red if ≥ 20% and yellow if between 5%
and 20%. The second dose vaccination is marked as light red if < 5% and yellow if betwe en 5% and 10%.
Target population for vaccination includes health workers, essential public service workers, older persons,
vulnerable populations and people aged 18 years and above and children aged 12 -17 years.
15
WHO Indonesia Situation Report – 76
who.int/indonesia• Continuous implementation of public health and social measures (PHSM)
throughout the country is important, even as the national vaccination coverage
increases and expands to additional target groups.9
• Increased testing rates were observed in several districts and provinces during the
implementation of emergency restrictions on public activities (Pemberlakuan
Pembatasan Kegiatan Masyarakat (PPKM) Darurat) from 3 to 25 July 2021. As of
17 October, all provinces have achieved the recommended benchmark of one
person tested per 1000 population per week. All provinces showed a weekly test
positivity proportion below 5% during the current reporting period.
• The coverage of second-dose vaccination among the older population continues
to be low in most provinces. As of 17 October, only DKI Jakarta recorded above
70% coverage among this target group. Eleven provinces continue to report
second-dose coverage below 10% among the older population: Aceh (4.8%), West
Sumatra (5.2%), North Maluku (5.7%), Papua (6.4%), Southeast Sulawesi (6.8%),
West Sulawesi (7.3%), West Papua (8.2%), Lampung (8.2%), Gorontalo (9.5%),
South Kalimantan (9.3%) and Central Sulawesi (9.8%). Continued efforts to
improve the accessibility to and awareness of the benefits of COVID-19
vaccination among older and high-risk populations remain critical to reduce
morbidity and mortality.
9
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance-publications
16
WHO Indonesia Situation Report – 76
who.int/indonesiaRECENT AND UPCOMING WHO RESOURCE MATERIALS
Table 3. Title and details of recent WHO resource materials
Source : https ://www.who.int/
Title Details
COVID-19 vaccine The COVID-19 vaccine tracker and landscape compiles detailed
tracker and information of each COVID-19 vaccine candidate in development
landscape, by closely monitoring their progress through the pipeline. The
15 October 2021 vaccine tracker: provides summary tables of COVID-19 vaccine
candidates in both clinical and pre-clinical development; provides
analysis and visualization for several COVID-19 vaccine candidate
categories; and tracks progress of each vaccine from pre-clinical,
Phase 1, Phase 2 through to Phase 3 efficacy studies, and Phase
4 registered as interventional studies. The database is updated
regularly.
Landscape of This document provides an overview of the different observational
observational studies studies that are being conducted to assess the effectiveness of
on the effectiveness COVID-19 vaccination, including key features in terms of study
of COVID-19 design, sample size, study population, key outcomes measured
vaccination (draft), and location of study.
15 October 2021
17
WHO Indonesia Situation Report – 76
who.int/indonesiaA SNAPSHOT OF WHO COURSES AND INFORMATION MATERIAL
Online WHO COVID-19 courses:
• Clinical management of patients with COVID-19: General considerations
• COVID-19 vaccination training for health workers
• Standard precautions: Environmental cleaning and disinfection
• Management of COVID-19 in long-term care facilities
• Operational planning guidelines and COVID-19
• Clinical management of severe acute respiratory infections
• Health and safety briefing for respiratory diseases – eProtect
WHO guidance:
• COVID-19 vaccine tracker and landscape
• Landscape of observational studies on
the effectiveness of COVID-19
vaccination (draft)
• ACT-Accelerator Strategic Review
• WHO SPRP 2021 Mid-term Report -
WHO Strategic Action Against COVID-19
• WHO COVID-19 SPRP: Updated Appeal
September 2021 - March 2022
• Antigen-detection in the diagnosis of
SARS-CoV-2 infection (interim guidance)
Infographics:
• Rumours to bust
• Back to school (for parents)
• Vaccine effectiveness
• Vaccine protection
• Precaution
Questions and answers:
• How to talk about vaccines
• COVID-19: Vaccines
• COVID-19: Vaccine research and development
• COVID-19: Vaccine access and allocation
Videos:
• Vaccines, variants & doses
• Vaccines, variants & mass gathering
• Pregnancy & COVID-19
• Post COVID-19 condition
• Transmission indoors and outdoors
For more information please feel free to contact: seinocomm@who.int
WHO Indonesia Reports
18
WHO Indonesia Situation Report – 76
who.int/indonesiaYou can also read
